(Q45091068)

9 December 2017

title

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer (English)

1 reference

9 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

5

1 reference

9 December 2017

Paola Alberti

7

0 references

Francesca Bergamo

object named as

Francesca Bergamo

8

0 references

Guido Cavaletti

object named as

Guido Cavaletti

2

0 references

Andreas A Argyriou

1

object named as

Andreas A Argyriou

1 reference

9 December 2017

Chiara Briani

3

1 reference

9 December 2017

Roser Velasco

4

1 reference

9 December 2017

Marta Campagnolo

6

1 reference

9 December 2017

Diego Cortinovis

9

1 reference

9 December 2017

Marina Cazzaniga

10

1 reference

9 December 2017

Cristina Santos

11

1 reference

9 December 2017

Konstantinos Papadimitriou

12

1 reference

9 December 2017

Haralabos P Kalofonos

13

1 reference

9 December 2017

language of work or name

English

0 references

publication date

11 July 2012

1 reference

9 December 2017

1 reference

9 December 2017

volume

119

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

438-444

1 reference

9 December 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

A review on oxaliplatin-induced peripheral nerve damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

A review of oxaliplatin and its clinical use in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Chemotherapy-induced peripheral neurotoxicity (CIPN): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Longitudinal assessment of oxaliplatin-induced neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

7 January 2021

Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

7 January 2021

Ocular changes with oxaliplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

7 January 2021

Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27732

7 January 2021

Identifiers

DOI

10.1002/CNCR.27732

1 reference

9 December 2017

1 reference